mRNA Vaccines Contain Prion Region
The COVID-19 virus and its vaccine sequences have a prion region on their surface spike proteins. Earlier in the pandemic and vaccine rollout, some researchers were concerned that these prion regions may promote incurable prion diseases, such as Creutzfeldt-Jakob disease (CJD).
What Are Prions?
Prions are proteins that exist naturally in the brain. They perform crucial tasks and are necessary for human health.
However, on rare occasions, a healthy prion may misfold into a pathogenic prion. This misfold is irreversible, and from then on, the pathogenic prion converts all healthy prions it encounters into pathogenic prions.
Other researchers have also proposed that Parkinson’s disease and Alzheimer’s disease, both of which exhibit an accumulation of misfolded proteins, may also be prion diseases.
Prions are defined by their amino acid sequences. Prion-like sequences are rich in glutamine and asparagine amino acids, and human or foreign proteins that contain such regions are at risk of initiating prion diseases.
“Amino acid sequence can tell us if a protein can potentially act as a prion and show prion-like functions,” said Vladimir Uversky, PhD, a professor at the University of South Florida specializing in molecular medicine. “Not all proteins with prion-like sequences will undoubtedly act as prions. Even prion protein itself will cause prion disease in very few cases.
How Would mRNA Vaccines Form Prion Proteins?
One can think of mRNA vaccines as instructions used to make spike proteins. In the case of COVID-19 vaccines, the mRNA vaccines contain a high percentage of pseudouridine, which is less common in the human body. The extra pseudouridine makes the process more prone to “frameshift errors.”
Frameshift errors occur when the cell’s protein production machinery accidentally misses one or two bases in the mRNA sequence. Since mRNA bases are read in groups of threes, a frameshift breaks up the original sets of the sequence, affecting all sequences downstream of the error.
In his research, Mr. Perez found a frameshift by one base retains the prion-like sequences, while a frameshift by two bases eliminates them.
Spike Proteins and Prion Diseases in the Literature
Numerous papers in the literature have linked COVID-19 spike protein to prion formations.
The authors found specific spike protein sequences carried amyloid sequences and extracted them. When these sequences were supplemented with human prion and amyloid proteins, the spike sequences accelerated the proteins’ aggregation.
Neurologist Dr. Suzanne Gazda told The Epoch Times she is very concerned about the implications of prion disease acceleration and formation due to COVID-19 vaccination and infections.
Several studies have linked COVID-19 and its vaccines with prion diseases.
Around one to two weeks after administration, he became forgetful; two months later, he began losing his ability to find words. By the third to fourth month, he had developed a progressive speech disorder, confusion, agitation, and involuntary contraction of his left arm and leg.
Three months post-infection, the patient reported loss of coordination in his left arm and loss of reflexes in his legs.
Source: Epoch Times
Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
Wisenox
| #
Patent: US 2015/0030576A1
“METHODS AND COMPOSITIONS FOR
TARGETING AGENTS INTO AND ACROSS
THE BLOOD-BRAIN BARRIER”
Stephane Bancel, Moderna
Excerpt:
Nanoparticle Mimics
0486 The modified nucleic acid molecules and mmRNA of the invention may be encapsulated within and/or absorbed to a nanoparticle mimic. A nanoparticle mimic can mimic the
delivery function organisms or particles Such as, but not limited to, pathogens, viruses, bacteria, fungus, parasites, prions and cells. As a non-limiting example the modified mRNA of
the invention may be encapsulated in a non-viron particle which can mimic the delivery function of a virus (see International Pub. No. WO2012006376 herein incorporated by
reference in its entirety).
This patent is cited in Moderna Covid patent 10703789.
Reply